---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-012493"
form_type: "8-K"
ticker: "NRC"
cik: "0000070487"
company_name: "NRC HEALTH"
filed_at: "2023-05-04T23:59:59+00:00"
generated_at: "2026-06-15T23:30:00.592401+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "medium"
source: SEC EDGAR
---

# National Research Q1 EPS falls to $0.28 from $0.34; capital allocation unchanged

## Summary
- Diluted EPS $0.28 for Q1 2023, down from $0.34 in Q1 2022.
- Company funded $2.9M for innovation and growth, $3.0M for dividends, $2.0M for share repurchases.
- Board maintains capital allocation priorities: innovation, M&A, dividends, buybacks.
- Announced MyView to integrate patient insights into EHR to support personalized care.
- Expanding sales and marketing resources for Human Understanding Program.

## SEC filing metadata
- accession: 0001437749-23-012493
- form_type: 8-K
- ticker: NRC
- cik: 0000070487
- company_name: NRC HEALTH
- filed_at: 2023-05-04T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: medium
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/70487/000143774923012493/0001437749-23-012493-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/70487/000143774923012493/nrc20230503_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-012493
- JSON: https://secwatch.observer/filing/0001437749-23-012493.json
- Plain text: https://secwatch.observer/filing/0001437749-23-012493.txt

## Key facts
- Earnings Releases
  NRC HEALTH reported the first quarter ended March 31, 2023 results: EPS Diluted earnings per share decreased to $0.28 for the quarter ended March 31, 2023.
  - Period: the first quarter ended March 31, 2023
  - EPS: Diluted earnings per share decreased to $0.28 for the quarter ended March 31, 2023
  - Result: reported results
  source text: On May 2, 2023, National Research Corporation, a Delaware corporation (the "Company"), issued a press release announcing its financial and operating results for the first quarter ended March 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/70487/000143774923012493/0001437749-23-012493-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.